[go: up one dir, main page]

NO830966L - Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse - Google Patents

Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse

Info

Publication number
NO830966L
NO830966L NO830966A NO830966A NO830966L NO 830966 L NO830966 L NO 830966L NO 830966 A NO830966 A NO 830966A NO 830966 A NO830966 A NO 830966A NO 830966 L NO830966 L NO 830966L
Authority
NO
Norway
Prior art keywords
sulphonyluric
ingredients
procedures
compounds
preparation
Prior art date
Application number
NO830966A
Other languages
English (en)
Norwegian (no)
Inventor
Volker Hitzel
Rudi Weyer
Karl Geisen
Harald Ritzel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO830966L publication Critical patent/NO830966L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
NO830966A 1982-03-19 1983-03-18 Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse NO830966L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823210063 DE3210063A1 (de) 1982-03-19 1982-03-19 Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung

Publications (1)

Publication Number Publication Date
NO830966L true NO830966L (no) 1983-09-20

Family

ID=6158708

Family Applications (1)

Application Number Title Priority Date Filing Date
NO830966A NO830966L (no) 1982-03-19 1983-03-18 Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse

Country Status (12)

Country Link
EP (1) EP0089597A3 (da)
JP (1) JPS58170760A (da)
KR (1) KR840004081A (da)
AU (1) AU1266383A (da)
DE (1) DE3210063A1 (da)
DK (1) DK125583A (da)
ES (1) ES8401946A1 (da)
FI (1) FI830898L (da)
GR (1) GR77163B (da)
NO (1) NO830966L (da)
PT (1) PT76411B (da)
ZA (1) ZA831910B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002081728A2 (en) * 2001-04-06 2002-10-17 Smithkline Beecham Corporation Quinoline inhibitors of hyak1 and hyak3 kinases
JP5887345B2 (ja) 2010-08-27 2016-03-16 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Ｋｃｎｑ２／３調節因子としての置換２−アミノ−キノリン−３−カルボキサミド
WO2012025239A1 (en) 2010-08-27 2012-03-01 Grünenthal GmbH Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as kcnq2/3 modulators
PE20131379A1 (es) * 2010-08-27 2013-11-29 Gruenenthal Chemie 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores kcnq2/3
BR112013004721A2 (pt) * 2010-08-27 2016-05-17 Gruenenthal Gmbh "quinolina-3-carboxamidas substituídas como moduladores de kcnq2/3"
CA2807886A1 (en) 2010-09-01 2012-03-08 Gruenenthal Gmbh Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as kcnq2/3 modulators
TWI631105B (zh) * 2013-01-31 2018-08-01 維泰克斯製藥公司 作爲鈉通道調節劑之喹啉及喹噁啉醯胺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819633A (en) * 1970-04-01 1974-06-25 Erba Carlo Spa (iso)quinolyl sulfonylureas having antidiabetic activity
DE2621958A1 (de) * 1976-05-18 1977-12-08 Hoechst Ag Benzolsulfonylharnstoffe und verfahren zu ihrer herstellung
DE3134780A1 (de) * 1981-09-02 1983-03-10 Hoechst Ag, 6000 Frankfurt "sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung"

Also Published As

Publication number Publication date
FI830898L (fi) 1983-09-20
JPS58170760A (ja) 1983-10-07
DK125583D0 (da) 1983-03-18
AU1266383A (en) 1983-09-22
DE3210063A1 (de) 1983-09-22
PT76411A (de) 1983-04-01
GR77163B (da) 1984-09-10
ES520706A0 (es) 1984-01-01
ES8401946A1 (es) 1984-01-01
ZA831910B (en) 1983-11-30
EP0089597A3 (de) 1984-05-09
FI830898A0 (fi) 1983-03-17
DK125583A (da) 1983-09-20
EP0089597A2 (de) 1983-09-28
PT76411B (de) 1985-12-16
KR840004081A (ko) 1984-10-06

Similar Documents

Publication Publication Date Title
NO803855L (no) Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser og deres anvendelse
DK110183D0 (da) Carboxyalkyldipeptider, fremgangsmade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK573384D0 (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK214090D0 (da) 5-aminosulfonylalkyl-indolderivater, fremgangsmaade og mellemprodukt til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
DK288184A (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK460283D0 (da) Fremgangsmade til fremstilling af topiske farmaceutiske praeparater
DK165949C (da) 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne
DK110886A (da) Hidtil ukendte sulfonylaminoforbindelser, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater, der indeholder forbindelserne
DK165112C (da) 2,2'-iminobisethanolderivater, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende disse
DK161703C (da) Ferrikomplekser af hydroxypyridinforbindelser, farmaceutiske praeparater indeholdende saadanne komplekser, samt anvendelsen af saadanne komplekser til fremstilling af farmaceutiske praeparater
NO820200L (no) Fremgangsmaate til fremstilling av fosforylforbindelser, i foerste rekke heksapyranoseforbindelser samt farmasoeytiske preparater inneholdende disse
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
NO822671L (no) Farmasoeytisk virksomme forbindelser og fremgangsmaate for deres fremstilling.
DK160150C (da) Benzothiazinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende samme
DK159652C (da) Cholecalciferolderivater, disse derivater til brug som terapeutisk aktive substanser, fremgangsmaade til fremstilling deraf samt farmaceutisk praeparat baseret paa disse cholecalciferolderivater
DK127588A (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK48482A (da) Azopigmentpraeparater,fremgangsmaade til deres fremstilling og deres anvendelse
NO790917L (no) N-oksacyklyl-alkyl-piperidin, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser, samt deres terapeutiske anvendelse
DK306982A (da) Aerosol-praeparater paa vmadbasis og fremgangsmaade til deres fremstilling
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
NO830966L (no) Sulfonylurinstoffer, fremgangsmaate til deres fremstilling, farmasoeytiske preparater paa basis av disse forbindelser, og deres anvendelse
NO822062L (no) Substituerte imidazo(1,5-alfa)pyridiner, fremgangsmaate til deres fremstilling, farmasoeytiske preparater inneholdende disse forbindelser samt deres terapeutiske anvendelse
DK162984C (da) 1-(2-ar-2-halogen-2-ethenyl)-1h-azoler, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK617684A (da) 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser
DK402083D0 (da) Sulfamoylbenzophenon-derivater, fremgangsmade til fremstilling deraf, deres anvendelse samt farmaceutiske praeparater pa basis af disse forbindelser